undefined
EUTM file information

018526377

Remi


August 2, 2021

Trademark Summary

The trademark Remi was filed by Remi Health GmbH i.Gr., a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on October 20, 2021, and received one opposition filed on January 12, 2022 by DENTAURUM GmbH & Co. KG on Likelihood of confusion. the opponent was represented by HOEGER, STELLRECHT & PARTNER PATENTANWÄLTE MBB and proceedings were handled in German, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued January 12, 2022

The application was filed in German, and German was also language of all opposition proceedings (English was selected as the second language).


Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Pharmaceutical preparations, excluding the following goods: Preparations for use in dentistry or orthodontics
    2. Medical and forensic diagnostic test strips consisting primarily of reagents for the specimen collection for detecting sexually transmitted infections/diseases STIs/STDs, diabetes, prostate specific antigen (PSA)
    3. Diagnosis preparations for applications/tests for medical purposes.
  • The mark was filed in class 35 with following description of goods:
    1. Advertising and public relations
    2. Business management, marketing and network management
    3. Computerised data processing
    4. Computerized file management
    5. Collecting and systematic ordering of data in computer databases
    6. Retail and wholesale services, Including online mail order, in relation the following goods: medicated preparations, Testing for diagnostic or treatment purposes.
  • The mark was filed in class 44 with following description of goods:
    1. Medical testing for diagnostic or treatment purposes
    2. Monitoring and reporting services
    3. Medical diagnostic tests for sexually transmitted infections/diseases (STIs/STDs), diabetes, prostate specific antigen (PSA), testosterone, sexually transmitted diseases, cancer, genetic anomalies and disorders, fertility and stillbirth problems, namely the self-collection of biological specimens for laboratory tests for medical purposes at home or in pharmacies
    4. Telemedical services, in particular Patient screening, advanced patient diagnostics and online doctor's consultation and support for the prevention of cancer and chronic diseases
    5. Online medical services and Medical consultations and Online pharmaceutical services and Pharmaceutical advice
    6. Providing of online medical consultations
    7. Providing of online medical, health-related and pharmaceutical information, advice and consultancy
    8. Online provision of information, in relation to the following fields: Medical treatment services
    9. Online prescription services, namely the online issuance of prescriptions by doctors, nurses and healthcare providers and the processing and preparation thereof by pharmacists
    10. Providing of online medical files
    11. Communications, Advice and Counselling services relating to all of the aforementioned services.